Siegfried Acceleration Hub
Maximize speed to clinical from the start
Accelerate your path to clinical. The Siegfried Acceleration Hub delivers development and manufacturing for early-phase programs in the US.
End-to-end life cycle management
Providing services from preclinical through commercial, including scale-up, tech transfer, validation and launch. DMFs throughout the US, Canada, Japan and the EU.
HIPO and controlled substances
Offering services for highly potent molecules with an OEL of <0.1 mg/m3. DEA registrations (both international and domestic) from research through manufacturing at all levels of controlled substances from CI-CV.
Accelerate speed to clinical
Your early-phase drug development needs a partner who can move fast. Access rapid speed-to-clinical through phase-appropriate analytical and development services, regulatory expertise, and compliant quality systems—all with the capability to manage highly potent and controlled APIs. The Siegfried Acceleration Hub in the US is designed around what you need in early-phase development and manufacturing.
More than 25 years of experience
An agile team with extensive experience in accelerating drug development through early phases, backed by Siegfried's 150 years of development expertise.
Based in the
United States
Regulatory compliance, transparency, and faster development by eliminating offshore transfer risks. Physical proximity enables real-time collaboration, reducing delays and ensuring efficient, sustainable scale-up.
Seamless transfer into Siegfried's network
Seamless transfer into Siegfried's global network, from early-phase to commercial manufacturing. All from a single supplier.
Our technologies and capabilities
Insights on our capabilities
Ask better, move faster: Questions that will accelerate the speed of your program to clinical
Subscribe now to get more expert insights

Get in touch
Contact us for more information about the Siegfried Acceleration Hub and its offerings